Lava Therapeutics grabs $83m Series C
Lava Therapeutics, a Dutch and U.S. biotech company, has raised $83 million in Series C funding.
17 September 2020•1 min read
Lava Therapeutics, a Dutch and U.S. biotech company, has raised $83 million in Series C funding.